# Spinal Marginally Hyperbaric Ropivacaine for Cesarean Delivery

> **NCT03142880** · NA · UNKNOWN · sponsor: **Qilu Hospital of Shandong University (Qingdao)** · enrollment: 120 (estimated)

## Conditions studied

- Anesthesia, Spinal

## Interventions

- **COMBINATION_PRODUCT:** hyperbaric ropivacaine

## Key facts

- **NCT ID:** NCT03142880
- **Lead sponsor:** Qilu Hospital of Shandong University (Qingdao)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05
- **Primary completion:** 2017-09
- **Final completion:** 2017-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03142880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03142880, "Spinal Marginally Hyperbaric Ropivacaine for Cesarean Delivery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03142880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*